Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Scott

Showing results (201-210 of 254) with videos related to

Pageof 26
Sort By:
BMC Public Health|April 3, 2022
Feasibility, acceptability, and short-term impact of a brief sexually transmitted infection intervention targeting U.S. Military personnel and family membersAnjali Kunz, Amber Moodley, Donn J Colby, et al.
Biopharmaceutics & Drug Disposition|June 16, 2007
Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligandsAndrew Pike, Susan M Cook, Alan P Watt, et al.
American Journal of Hematology|July 18, 2013
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trialOfelia Alvarez, Nancy A Yovetich, J Paul Scott, et al.
The Journal of Pediatrics|September 13, 2011
Effects of chronic transfusions on abdominal sonographic abnormalities in children with sickle cell anemiaMary Beth McCarville, Zora R Rogers, Sharada Sarnaik, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2006
Comparison of lorazepam [7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one] occupancy of rat brain gamma-aminobutyric acid(A) receptors measured using in vivo [3H]flumazenil (8-fluoro 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester) binding and [11C]flumazenil micro-positron emission tomographyJohn R Atack, Paul Scott-Stevens, John S Beech, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2024
A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (STRIDE-6)Paul Scott, Miwa Haranaka, Jung Hyun Choi, et al.
Advances in Nutrition (Bethesda, Md.)|November 15, 2013
Resistant starch: promise for improving human healthDiane F Birt, Terri Boylston, Suzanne Hendrich, et al.
Pediatric Blood & Cancer|August 10, 2011
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overloadRussell E Ware, William H Schultz, Nancy Yovetich, et al.
The Lancet. Infectious Diseases|May 31, 2017
Defining sepsis: inspiring proposals meet practical realitiesMelinda Munang, Saleem Chaudhri, Methini Himayakanthan, et al.
BMJ (Clinical Research Ed.)|April 27, 2017
Sepsis quality standards are laudable but have low specificityEd Moran, Melinda Munang, Cathleen Chan, et al.
Pageof 26

Showing results (201-210 of 254) with videos related to

Sort By:
Pageof 26
BMC Public Health|April 3, 2022
Feasibility, acceptability, and short-term impact of a brief sexually transmitted infection intervention targeting U.S. Military personnel and family membersAnjali Kunz, Amber Moodley, Donn J Colby, et al.
Biopharmaceutics & Drug Disposition|June 16, 2007
Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligandsAndrew Pike, Susan M Cook, Alan P Watt, et al.
American Journal of Hematology|July 18, 2013
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trialOfelia Alvarez, Nancy A Yovetich, J Paul Scott, et al.
The Journal of Pediatrics|September 13, 2011
Effects of chronic transfusions on abdominal sonographic abnormalities in children with sickle cell anemiaMary Beth McCarville, Zora R Rogers, Sharada Sarnaik, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2006
Comparison of lorazepam [7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one] occupancy of rat brain gamma-aminobutyric acid(A) receptors measured using in vivo [3H]flumazenil (8-fluoro 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester) binding and [11C]flumazenil micro-positron emission tomographyJohn R Atack, Paul Scott-Stevens, John S Beech, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2024
A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (STRIDE-6)Paul Scott, Miwa Haranaka, Jung Hyun Choi, et al.
Advances in Nutrition (Bethesda, Md.)|November 15, 2013
Resistant starch: promise for improving human healthDiane F Birt, Terri Boylston, Suzanne Hendrich, et al.
Pediatric Blood & Cancer|August 10, 2011
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overloadRussell E Ware, William H Schultz, Nancy Yovetich, et al.
The Lancet. Infectious Diseases|May 31, 2017
Defining sepsis: inspiring proposals meet practical realitiesMelinda Munang, Saleem Chaudhri, Methini Himayakanthan, et al.
BMJ (Clinical Research Ed.)|April 27, 2017
Sepsis quality standards are laudable but have low specificityEd Moran, Melinda Munang, Cathleen Chan, et al.
Pageof 26